Comparative analysis of the Memorial Sloan Kettering Bowel Function Instrument and the Low Anterior Resection Syndrome Questionnaire for assessment of bowel dysfunction in rectal cancer patients after low anterior resection.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 30 09 2020
revised: 08 12 2020
accepted: 28 12 2020
pubmed: 7 1 2021
medline: 19 8 2021
entrez: 6 1 2021
Statut: ppublish

Résumé

Neoadjuvant therapy and total mesorectal excision (TME) for rectal cancer are associated with bowel dysfunction symptoms known as low anterior resection syndrome (LARS). Our study compared the only two validated instruments-the LARS Questionnaire (LARS-Q) and the Memorial Sloan Kettering Bowel Function Instrument (MSK-BFI)-in rectal cancer patients undergoing sphincter-preserving TME. One hundred and ninety patients undergoing sphincter-preserving TME for Stage I-III rectal cancer completed the MSK-BFI and LARS-Q simultaneously at a median time of 12 (range 1-43) months after restoration of bowel continuity. Associations between the MSK-BFI total/subscale scores and the LARS-Q score were investigated using Spearman rank correlation (r Major LARS was identified in 62% of patients. The median MSK-BFI scores for no LARS, minor LARS and major LARS were 76.5, 70 and 57, respectively. We found a strong association between MSK-BFI and LARS-Q (r The MSK-BFI and LARS-Q showed good correlation and similar discriminant validity. As the LARS-Q is easier to complete, it may be considered the preferred tool to screen for bowel dysfunction.

Identifiants

pubmed: 33405307
doi: 10.1111/codi.15515
pmc: PMC8023229
mid: NIHMS1682688
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-460

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2021 The Association of Coloproctology of Great Britain and Ireland.

Références

Dis Colon Rectum. 2005 Jul;48(7):1353-65
pubmed: 15868235
JAMA Oncol. 2018 Jun 14;4(6):e180071
pubmed: 29566109
Colorectal Dis. 2017 Aug;19(8):713-722
pubmed: 28612460
Ann Gastroenterol. 2019 Mar-Apr;32(2):185-192
pubmed: 30837792
Ann Surg. 2019 Jun;269(6):1124-1128
pubmed: 31082911
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
Curr Colorectal Cancer Rep. 2015;11:37-43
pubmed: 25663833
Dis Colon Rectum. 2020 Mar;63(3):274-284
pubmed: 32032141
J Clin Oncol. 2011 Oct 1;29(28):3768-74
pubmed: 21859995
Qual Life Res. 2016 May;25(5):1123-30
pubmed: 26590838
J Clin Oncol. 2011 Apr 10;29(11):1465-71
pubmed: 21383294
Int J Colorectal Dis. 2017 Mar;32(3):409-418
pubmed: 27796496
Colorectal Dis. 2020 Oct;22(10):1367-1378
pubmed: 32346917
Dis Colon Rectum. 2014 May;57(5):585-91
pubmed: 24819098
J Clin Oncol. 2015 Nov 10;33(32):3733-40
pubmed: 26324362
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Dis Colon Rectum. 2017 Feb;60(2):240-247
pubmed: 28059921
Br J Surg. 2013 Sep;100(10):1377-87
pubmed: 23939851
Lancet Oncol. 2012 Sep;13(9):e403-8
pubmed: 22935240
Dis Colon Rectum. 2020 Jul;63(7):897-902
pubmed: 32217857
Dis Colon Rectum. 2017 Oct;60(10):1032-1040
pubmed: 28891846
Dis Colon Rectum. 2019 Jan;62(1):14-20
pubmed: 30394987
Ann Surg. 2012 May;255(5):922-8
pubmed: 22504191
J Gastrointest Surg. 2019 Apr;23(4):800-807
pubmed: 30350191
Lancet Oncol. 2014 Dec;15(13):1481-1492
pubmed: 25456367
Gut. 2018 Apr;67(4):688-696
pubmed: 28115491
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436

Auteurs

Felipe F Quezada-Diaz (FF)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Hossam Elfeki (H)

Department of Surgery, Mansoura University Hospital, Mansoura, Egypt.

Katrine J Emmertsen (KJ)

Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects After Cancer in the Pelvic Organs, Aarhus University Hospital, Aarhus, Denmark.

Emmanouil P Pappou (EP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Rosa Jimenez-Rodriguez (R)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Sujata Patil (S)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Søren Laurberg (S)

Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects After Cancer in the Pelvic Organs, Aarhus University Hospital, Aarhus, Denmark.

Julio Garcia-Aguilar (J)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH